Press release
Global Lentiviral Vector Market is Estimated US$ 506.7 Million by 2034 at an 11.5% CAGR | Fact.MR Report
Lentiviral Vector Market
The changing genetic medicine landscape is a central driver augmenting the demand for lentiviral vectors. The push for genetic engineering is fueling the development of the market. Firms are exploring vast research to increase the applications of lentiviral vectors.
The general application of lentiviral vectors in basic research attests to their versatility and efficiency in transducing cells. Suppliers of these vectors position themselves as crucial partners with researchers, driving innovations in gene function and regulation.
The pharmaceutical and biotech industries are witnessing growth in funding and investment as a result of the growing interest in gene therapies and advancements of related technologies.
This financial assistance facilitates the production, testing, and marketing of commodities based on lentiviral vectors. Lentiviral vector safety profiles have been optimized, targeting immunogenicity and off-targeting. These developments enhance the overall attractiveness of lentiviral vectors for many therapeutic uses.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9592
Key Takeaways from Market Study:
The estimated market value of the lentiviral vector market in 2024 is US$ 170.7 million.
The market is forecasted to reach a valuation of US$ 506.7 million by 2034.
The global market is expected to grow at a CAGR of 11.5% from 2024 to 2034.
The kits product type segment is projected to expand at a CAGR of 11.6% during the forecast period.
The cancer indication segment is anticipated to grow at a rate of 11.0% CAGR from 2024 to 2034.
North America holds a significant share of 37.3% of the lentiviral vector market in 2024.
The East Asia market size accounts for 14.5% of the total lentiviral vector market in 2024
Leading Players Driving Innovation in the Lentiviral Vector Market:
Oxford BioMedica; Thermo Fisher Scientific; Lonza Group; Sirion Biotech; ViGene Biosciences; SIRION Biotech; Creative Biolabs; GenScript Biotech Corporation; Addgene; VectorBuilder
Major Trends Driving Market Growth:
The increasing application of gene therapy is transforming medicine and driving the demand for advanced gene delivery vectors like lentiviral vectors. Businesses well-positioned to supply these vectors stand to gain from the expanding market opportunities.
Investment in robust manufacturing capabilities and regulatory compliance can place businesses in position to gain significant market share as gene therapy transitions from experimental to mainstream therapy. Such businesses are able to utilize their expertise to meet increasing demand for effective gene delivery technology.
One significant trend shaping market dynamics is the continuous development of lentiviral vector engineering and design methods. Innovative companies significantly invest in research and development to enhance vector safety, mitigate immunogenicity concerns, and optimize delivery efficiency.
Fine vector design enhances market competitiveness while at the same time considering safety and regulatory issues. Companies that show superior vector engineering capabilities become more attractive to collaborators, investors, and potential buyers, making them market leaders in this competitive sector.
Browse Full Report: https://www.factmr.com/report/lentiviral-vector-market
Lentiviral Vector Market News:
In April 2023, SK Pharmateco's clinical and commercial viral vector manufacturing business unit, Yposkesi, released LentiSure, an advanced platform for lentiviral (LV) vector production intended to improve the robustness and efficiency of lentivirus production.
In September 2022, to decrease the course of neurological dysfunction in boys between 4 and 17 with early, active cerebral adrenoleukodystrophy (CALD), the FDA approved fast approval of the gene therapy elivaldogene autotemcel, commonly referred to as eli-cel. Eli-cel is now the first lentiviral vector gene treatment for CALD patients and the second for severe genetic disease patients in the United States. It is also set to be marketed under the name SKYSONA
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the global lentiviral vector market presenting historical market data (2019-2023) and forecast statistics for the period of 2024-2034.
The lentiviral vector market is segmented based on product type, indication, end user, and region. By product type, the market includes kits, reagents, and consumables. Based on indication, it covers cancer, genetic disorders, infectious diseases, veterinary diseases, and others. The market is further categorized by end users, including biotechnology companies, pharmaceutical companies, contract research organizations (CROs), and academic and research institutes.
Geographically, the market is divided into North America, Europe, Latin America, East Asia, South Asia & Oceania, and the Middle East & Africa.
Check out More Related Studies Published by Fact.MR Research:
Gene Therapy Market - https://www.factmr.com/report/4648/gene-therapy-market
Gene Therapy for SCID Market - https://www.factmr.com/report/gene-therapy-for-scid-market
CRISPR and Cas Genes Market - https://www.factmr.com/report/4823/crispr-and-cas-genes-market
Diagnostic Imaging Centers Market - https://www.factmr.com/report/diagnostic-imaging-centers-market
Orthopedic Navigation Systems Market - https://www.factmr.com/report/orthopedic-navigation-systems-market
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Lentiviral Vector Market is Estimated US$ 506.7 Million by 2034 at an 11.5% CAGR | Fact.MR Report here
News-ID: 3953727 • Views: …
More Releases from Fact.MR Market Research
Undecylenic Acid Market Is Expected To Grow At A CAGR Of 4% During The Forecast …
Undecylenic acid, an unsaturated fatty acid derived from castor oil, is recognized for its antifungal properties. It is widely used in medical treatments for skin infections, as well as in the production of cosmetics and personal care products. The market is projected to witness higher single-digit growth globally during the forecast period, with regions like North America and Europe leading in volume, while the Middle East and Africa (MEA) are…
Whey Cheese Market to Reach USD 21.6 Billion by 2035 Amid Rising Demand for Func …
The global whey cheese market is witnessing remarkable growth, driven by increasing consumer preference for protein-rich, functional, and sustainable dairy products. According to recent research, the market is expected to reach USD 21.6 billion by 2035, up from USD 10.5 billion in 2024, marking a robust compound annual growth rate (CAGR) of 6.8% during the forecast period from 2025 to 2035.
Rising Demand for Functional and Protein-Rich Foods Fuels Market Expansion
The…
Enzyme-Enhanced Ingredients Market to Reach USD 11,657 Million by 2035, Driven b …
The global enzyme-enhanced ingredients market is poised for remarkable growth, with the industry projected to reach USD 11,657 million by 2035, up from USD 5,955 million in 2024. This expansion is expected to occur at a robust compound annual growth rate (CAGR) of 6.5% between 2025 and 2035.
The surge in demand is primarily driven by the rising adoption of enzyme-based solutions across food, beverage, and nutraceutical industries, alongside an…
Glycine Market Set to Reach USD 2,825.8 Million by 2035, Driven by Expanding App …
The global glycine market is poised for remarkable growth over the next decade, with market value projected to surge from USD 1,356.4 million in 2024 to USD 2,825.8 million by 2035.
During the forecast period from 2025 to 2035, the industry is expected to expand at a robust CAGR of 6.9%, reflecting the increasing demand for this versatile amino acid across multiple end-use sectors. Glycine, the simplest amino acid, is…
More Releases for Lentiviral
Key Factor Supporting Lentiviral Vector Market Development in 2025: Lentiviral V …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Lentiviral Vector Market Size By 2025?
The size of the lentiviral vector market has expanded significantly in the past few years. Projections show an increase from $14.37 billion in 2024 to $16.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.7%. Factors…
Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In …
How Is the Lentiviral Vector Market Projected to Grow, and What Is Its Market Size?
The lentiviral vector market will grow from $14.37 billion in 2024 to $16.62 billion in 2025, at a CAGR of 15.7%. This market is expanding due to the growing prevalence of genetic disorders, increasing demand for gene delivery systems, biotech and pharmaceutical investments, and regulatory approvals for related therapies.
The lentiviral vector market is expected to grow…
Lentiviral Vector Market Size, Share, and Growth Opportunities 2023 -2030
This Lentiviral Vector Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply…
Lentiviral Vectors Market Size 2024 to 2031.
Market Overview and Report Coverage
Lentiviral vectors are a type of viral vector used in gene therapy to deliver genetic material into target cells for both research and therapeutic purposes. These vectors are derived from lentiviruses, a type of retrovirus that can integrate their genetic material into the DNA of host cells.
The Lentiviral Vectors Market is poised for significant growth in the coming years, with a projected CAGR of…
The Lentiviral Vectors Market To Strive With Vertical Saas
Lentiviral vectors are gene delivery mechanisms that are produced from the lentivirus of the human immunodeficiency virus type 1 (HIV-1). These vectors are mainly incompetent for replication, and hence, regarded as generally safe. Yet, they can successfully integrate into the genomic DNA of a wide variety of dividing and non-dividing mammalian cell types.
With recorded sales of US$ 127.6 Mn in 2021, the global lentiviral vectors market is predicted to experience…
Lentiviral Vector Manufacturing Market Size
According to a new market research report published by Global Market Estimates, the Global Lentiviral Vector Manufacturing Market is projected to grow at a CAGR value of 17.8% from 2022 and 2027.
Charles River Laboratories, Vivebiotech, Thermo Fisher Scientific. Inc., GenScript, Creative Biogene, OriGene Technologies, Inc., Oxford Biomedica, Merck KGaA, Takara Bio, Pall Corporation, ITSBio Inc., ANDELYN BIOSCIENCES, Sino Biological Inc., Cellomics Technology, LLC, Virica Biotech, Cell Biolabs, Inc., SignaGen…
